Amarin Corp Plc (AMRN)

[jomama9231]

FISHing for the Miracle of Eicosapentaenoic Acid

John J.P. Kastelein, M.D., Ph.D., and Erik S.G. Stroes, M.D., Ph.D.
January 3, 2019
N Engl J Med 2019; 380:89-90
DOI: 10.1056/NEJMe1814004
This article has no abstract; the first 100 words appear below.
Bhatt et al. report in the Journal the results of the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT), in which 8179 high-risk patients who had elevated triglyceride levels and had been receiving statin therapy were randomly assigned to receive 2 g of icosapent ethyl twice daily or placebo containing mineral oil.1 The patients were enrolled mostly on the basis of secondary prevention (71%), and almost 60% had diabetes. At baseline, low-density lipoprotein (LDL) cholesterol levels were well controlled among the patients (median value, 75.0 mg per deciliter [1.94 mmol per liter]), and triglyceride levels were slightly elevated (median . . .

A commentary article about reduce it. Appreciates the big results of reduce it despite the authors getting paid by azn and other biotech firms creating bias.
Btw NEJM has 552 K followers on twitter. Hopefully these posts and articles spark some future scripts.